6. H
I
S
T
O
R
Y
Developed in 1940s by Imperial Chemical
Industries, England
Marketed in 1954 as antiseptic for skin wounds
Later, widely used in medicine and surgery
including obstetrics, gynaecology, urology and pre-
surgical skin preparation
In dentistry, initially as pre-surgical disinfectant of
mouth and in Endodontics
7. 1969 - Schroeder investigated
Plaque inhibition by CHX
1970 - Loe and Schiott did a definitive
study on it
Rinsing for 60 sec BD with 10ml of a
0.2% CHX solution without normal tooth
cleaning inhibits plaque regrowth and
development of gingivitis
8. C
H
E
M
I
S
T
R
Y
BISBIGUANIDE antiseptic
Symmetrical molecule
4 CHLOROPHENYL rings and 2
BIGUANIDE groups
Connected by a Central
HEXAMETHYLENE bridge
2 POSITIVE CHARGES on either
side of the hexamethylene bridge
Strong BASE
DICATIONIC at pH levels >3.5
Extremely INTERACTIVE with anions
due
to its dicationic nature